Sunshine Guojian Pharmaceutical Shanghai's (SHA:688336) net profit attributable to shareholders in the third quarter soared 101% year on year to 208.5 million yuan, according to a Shanghai bourse filing on Friday.
Earnings per share surged 100% year on year to 0.34 yuan.
Operating revenue jumped 38% from a year earlier to almost 474 million yuan.
The Chinese pharmaceutical company's shares dropped over 7% in the afternoon trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments